Step 1 topics → Reproductive → Erectile Dysfunction

Erectile Dysfunction

USMLE Step 1 trap: Misses ED as a sentinel marker for underlying cardiovascular disease. ED is often the first manifestation of systemic atherosclerosis and endothelial dysfunction, and should prompt cardiovascular risk assessment.

Erectile dysfunction is low-yield on USMLE Step 1, but the two things it does test are high-yield in their own right: ED as a cardiovascular sentinel event, and the PDE5 inhibitor-nitrate interaction. The physiology is straightforward — erection requires parasympathetic-driven NO release, cGMP accumulation, and smooth muscle relaxation in the corpus cavernosum. PDE5 degrades cGMP, so inhibiting PDE5 (sildenafil, tadalafil) prolongs erection. What the exam cares about is how this mechanism creates a dangerous overlap with nitrates, which also work through cGMP.

The trickier angle is recognizing ED as a disease marker, not just a complaint. When a 52-year-old man presents with ED in a vignette, the exam wants you to think atherosclerosis first, not performance anxiety. Vasculogenic ED — from endothelial dysfunction and reduced penile arterial flow — is the most common cause, and it shares the same pathophysiology as coronary artery disease. Psychogenic ED is a diagnosis of exclusion and is far less commonly the right answer than students expect.

Students lose points here in two specific ways: assuming ED in a middle-aged man is psychological, and assuming that separating doses of a PDE5 inhibitor and a nitrate makes the combination safe. Neither is true. USMLE Step 1 will test the nitrate contraindication in a clinical scenario — a man takes sildenafil, then gets chest pain and is given nitroglycerin, and the question asks what happens or what you should have asked first.

From real student decks
62%have cards covering this topic
41%have mature cards

Common misconceptions

Common mistake
Wrong: Erectile dysfunction in a middle-aged man is primarily a psychological problem.
Right: ED is often the first manifestation of systemic atherosclerosis and endothelial dysfunction, and should prompt cardiovascular risk assessment.
Psychogenic ED is real but rare relative to vasculogenic ED on Step 1 vignettes. The penis is supplied by small-caliber end arteries that are exquisitely sensitive to early endothelial dysfunction — which is why ED often precedes overt coronary or peripheral artery disease by years. When you see ED in a middle-aged man with any cardiovascular risk factors, the right mental model is 'canary in the coal mine for systemic atherosclerosis,' and the workup should include lipid panel, fasting glucose, and blood pressure evaluation. Anchoring on psychogenic cause delays that workup.
Common mistake
Wrong: PDE5 inhibitors are safe to combine with nitrates if the doses are separated in time.
Right: PDE5 inhibitors are absolutely contraindicated with nitrates regardless of timing due to risk of severe, potentially fatal hypotension.
The mechanism makes clear why timing doesn't matter: both nitrates and PDE5 inhibitors converge on cGMP accumulation in vascular smooth muscle, just from different directions. Nitrates donate NO → activate guanylyl cyclase → make more cGMP. PDE5 inhibitors block cGMP breakdown. Stack them at any interval and you get a massive, uncontrolled drop in systemic vascular resistance. Sildenafil has a half-life around 4 hours and tadalafil around 17 hours, so even 'separated' doses leave active drug on board. The contraindication is absolute — no dose separation makes this combination safe.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a middle-aged man with ED, recognize that vasculogenic (atherosclerotic) disease is the most likely cause and that ED should prompt formal cardiovascular risk stratification — not reassurance or referral for counseling.
  2. Explain the mechanism of PDE5 inhibitors (block cGMP degradation → prolonged smooth muscle relaxation) and identify why combining them with nitrates (which increase cGMP via NO) causes severe, potentially fatal hypotension — and that this contraindication is absolute regardless of how much time separates the doses.

Can you avoid these mistakes?

A 54-year-old man with hypertension and hyperlipidemia presents reporting inability to achieve erections for the past 6 months. He attributes it to work stress. What is the most likely underlying mechanism, and what should the workup include beyond urology referral?
A patient takes sildenafil on Friday night. On Saturday afternoon he develops chest pain and EMS administers sublingual nitroglycerin. His blood pressure drops to 60/40. Why did this happen, and what should the ER team avoid giving next?
A 45-year-old man with stable angina asks if he can use tadalafil. He takes isosorbide mononitrate daily. What is your answer, and does it matter that he plans to take the tadalafil 12 hours after his last nitrate dose?
Trace the NO → cGMP → smooth muscle relaxation pathway in a penile artery during normal erection. At which step do PDE5 inhibitors act, and how does this mechanistically explain both their therapeutic effect and their dangerous interaction with nitrates?

Related topics

Gonadal Differentiation (SRY, MIS, Testosterone) Müllerian vs Wolffian Duct Derivatives 5α-Reductase Deficiency Complete Androgen Insensitivity Syndrome (CAIS)

See how your Anki deck covers this topic.

Upload your deck for a free audit →